Acusphere nets $2.5M in financing
Article Thumbnail ImageFebruary 24, 2012 -- Ultrasound contrast developer Acusphere has secured $2.5 million in new debt financing.
Member Sign In:
MemberID or E-mail Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  

The company currently is conducting a special protocol assessment with the U.S. Food and Drug Administration (FDA) for a phase III study of its Imagify ultrasound contrast agent.

The study will compare stress ultrasound with Imagify to unenhanced stress ultrasound for detecting coronary artery disease.